PTI’s non-destructive micro leak tester can cut costs for companies using dye ingress, according to general manager Heinz Wolf, who demonstrated the technology to in-PharmaTechnologist at Interphex.
Canada’s Winpak has gained an exclusive license to use Reynolds Packaging’s manufacturing know-how in the production of packaging for the drug and healthcare industries.
The global economic downturn, impending blockbuster patent expiries and the wave of consolidation sweeping the pharmaceutical industry will drive demand for Patheon’s restructuring service according to CEO Wesley Wheeler.
Hewlett-Packard has made its high-volume digital press commercially available, which it claims can cut waste, warehousing and environmental impact compared to analogue printing.
Vetter Pharma-Fertigung (VPF), a specialist provider of pre-filled injection systems, has formed a new subsidiary, Vetter Pharma International (VPI) to take charge of sales, marketing and customer services.
Michael Schmitt, president of Alcan Global Pharmaceutical Packaging, believes a recovery in the global economy, the increasing demand for quality and the emergence of markets like India and Brazil will be key drivers for the packaging sector over the...
Catalent is adjusting its packaging operations by closing one facility and simultaneously expanding another, which it believes will improve the service offered to its folding carton customers.
US Biotechnology firm Cel-Sci has unveiled a new manufacturing process, cold 4°C Aseptic Filling, that it claims can improve the shelf-life and potency of biologic drugs produced using stem cells.
German coating technology specialist Driam hopes its new Driaconti-T continuous tablet coating platform will win over manufacturers wishing to improve process efficiency in times of economic gloom.
Patheon chief Wes Wheeler says the drop in Q1 losses the firm recently reported is due to the “restructuring activities and rigorous cost containment efforts” it enacted towards the end of last year.
Three plants owned by contract packaging maker Alcan have been cleared to produce containers for pharmaceutical products under the International Organization for Standardization’s ISO 15378:2006 guidelines.
It is not compulsory to respond to form 483s detailing deficiencies at a facility but the FDAs latest guidance fully recommends companies do so to avoid being issued with a warning letter.
This week in-PharmaTechnologist's Pharma Phacts podcast focuses on a nanotechnology method that could produce more effective barrier packaging using less material.
Valois Pharma is installing precision plastic molding capabilities at its manufacturing facility in Congers, New York, US as part of ongoing efforts to modernise its global manufacturing operations.
Compass Pharma Services is targeting contract drug developers and clinical research firms with a new microfilling offering that, it claims, helps reduce waste and may even make excipients unnecessary in some drugs.
US drugmaker and contract manufacturer Peregrine narrowed its losses in the second fiscal quarter ending October 31, as a result of cost-cutting measures.
Healthcare products company William Ransom & Son has finally published its financial results for the year ended March 31, 2008, and provided an update on efforts to turn around the troubled business.
The European Union’s long-awaited reform of pharmaceutical regulations known as the ‘pharmaceutical package’ was unveiled yesterday after months of consultation and debate.
Isogen will start operations in January at a new contract facility in Delaware that will provide small-scale sterile filling services to the pharmaceutical industry.
Contract research group Recipharm has leased AstraZeneca Biotech Laboratory (ABL) in Sodertalje, Sweden, bolting on recombinant protein and monoclonal antibody development capabilities to its offering.
US company Irvine Pharmaceutical Services is gearing up to launch a new subsidiary company to provide fill-and-finish services for biopharmaceutical companies.
Jubilant Organosys, India's largest custom research and manufacturing services (CRAMS) provider, has reorganised its business in North America in the wake of its recent acquisitions of HollisterStier Laboratories and Draxis Specialty Pharmaceuticals.
The pharmaceutical industry must adapt its processes and strategies to cope with a new, tougher operating environment, according to Stefan Borgas, CEO of Lonza.
After months of deliberations, a court in Iowa has opted to fine contract manufacturing company Cambrex $6,000 for safety violations after an explosion at its facility in Charles City.
Ahead of the “open house” at its facility in Monteriggioni, Siena, Italian machining specialist Marchesini spoke with in-PharmaTechnologist.com about the new plant and its role in the firm's offering to the drug industry.
Pfizer is shifting its research focus to those diseases where its sees the potential for the biggest treatment improvements and profits, while dropping eight disease areas including cholesterol.
Capsule specialist Capsugel has won the contract to make a highly-touted new anti-inflammatory developed by French biotechnology company NicOx as the product approaches registration.
Indian pharmaceutical companies are making their first forays in the biotechnology arena, helping the market expand from a standing start at the beginning of the decade to reach a value of $2bn in 2006-7, according to a recent report from KPMG.
Indian pharmaceutical company Lupin Ltd has expanded into Africa by acquiring a 60 per cent stake Pharma Dynamics, a generics company and contract manufacturer based in Cape Town, South Africa.
CMO NextPharma has signed a deal to make Aseptic Technologies “revolutionary” ‘closed-vial’ filling system available as part of its offering to clients.
Pharmatek Laboratories has opened its highly-potent and cytotoxic facility located in San Diego, US, just over a year after announcing its move into this growth area of contract manufacturing.
Outsourcing-Pharma.com presents its latest round-up of new appointments, employment moves and personnel news in the pharmaceutical contract services sector.
Bilcare GCS, the clinical supplies arm of Indian packaging giant Bilcare, has considerably expanded its Phase III trial offering in an effort to provide drugmakers with a complete package.
India’s contract manufacturing market is expected to rocket forward over the next couple of years to reach a value of $2.46bn in 2010, according to a just-released report from KPMG.
Haupt Pharma has completed its merger with fellow German companies Amareg and Wülfing Pharma to create a major new force in the European contract development and manufacturing sector, with around 1,500 staff and an annual turnover of €180m.
Canada’s Patheon put in another quarter of robust revenues growth in its third quarter, which coupled with cost-reduction measures helped the firm trim its net loss to $14.7m, down 75 per cent on a year ago.
A milestone payment from Bristol-Myers Squibb for the successful advancement of a project into clinical development, along with strong sales by its contract research and manufacturing services unit, prompted Albany Molecular Research Inc (AMRI) to hike...
Australia’s CSL Ltd has signed a $3.1bn agreement to acquire Talecris Biotherapeutics of the US and throw down the gauntlet to rival Baxter International in the plasma-based pharmaceutical sector.
in-PharmaTechnologist.com’s latest round up of products launched in the pharmaceutical manufacturing sector includes new offerings from Millipore, Sensor Products and Aspex.
Pharmaceutical company Enzon may hive off its entire specialty drugs division, including a manufacturing facility in Indianapolis, US, in the face of pressure from shareholder Carl Icahn.
Cambrex posted a 5 per cent hike in revenues in the second quarter, helped by its shift into contract controlled substance manufacture, although without favourable currency effects sales would have slipped back 2.6 per cent.
US packaging specialist West Pharmaceutical Services has carried the earnings momentum it generated in the first three months of the year through to the second quarter.
